Kv7.2 modulator therapy - Angelini Pharma
Alternative Names: Small molecule Kv7.2 programLatest Information Update: 26 May 2025
At a glance
- Originator OmniAB
- Class Small molecules
- Mechanism of Action KCNQ potassium channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified